V. Dietz et al., PERFORMANCE AND POTENCY OF TETANUS TOXOID - IMPLICATIONS FOR ELIMINATING NEONATAL TETANUS, Bulletin of the World Health Organization, 74(6), 1996, pp. 619-628
Neonatal tetanus (NT) is a major cause of mortality in developing coun
tries with over 400000 deaths estimated to occur annually. WHO has ado
pted the goal of eliminating NT worldwide, and a major strategy for if
s prevention is the administration of at least two properly spaced dos
es of tetanus toroid (TT) to women of childbearing age in high-risk ar
eas to protect passively their newborns at birth. In certain countries
the locally produced TT vaccine has been shown to be subpotent, while
other countries have reported NT among infants born to vaccinated wom
en. An extensive review of production and quality control procedures w
as carried out between 1993 and 1995 in 8 of 22 TT-producing countries
that also report NT cases, with a more superficial assessment being c
arried out in the remaining 14 countries. Only 4 of the 22 countries h
ave a functioning national control authority to monitor TT production
and vaccine quality. A total of 80 TT lots from 21 manufacturers in 14
of the 22 NT-reporting countries were tested for potency. Of these, 1
5 lots from eight manufacturers in seven countries had potency values
below WHO requirements. TT potency can also be compromised by improper
vaccine handling. To eliminate neonatal tetanus worldwide requires as
surance that all doses of TT meet WHO production and quality,requireme
nts and that the field effectiveness of TT is monitored through system
atic NT case investigations and assessment of coverage.